Other Long Term Assets - Nektar Therapeutics (NASDAQ:NKTR) - Alpha Spread

First Time Loading...

Watchlist Manager

Watchlist

Price: 1.27 USD 0.79%

Updated:

Nektar Therapeutics
Other Long-Term Assets

Last Value

3-Years 3-Y CAGR

5-Years 5-Y CAGR

10-Years 10-Y CAGR

Quarterly

Annual

|

Adjust for Inflation

Nektar Therapeutics
Other Long-Term Assets Peer Comparison

JNJ

BMY

PFE

MRK

LLY

Company		Other Long-Term Assets	CAGR 3Y	CAGR 5Y	CAGR 10Y
	Nektar Therapeutics NASDAQ:NKTR	Other Long-Term Assets $4.7m	CAGR 3-Years 49%	CAGR 5-Years 14%	CAGR 10-Years -18%
	Johnson & Johnson NYSE:JNJ	Other Long-Term Assets $19.9B	CAGR 3-Years 14%	CAGR 5-Years 13%	CAGR 10-Years 7%
	Bristol-Myers Squibb Co NYSE:BMY	Other Long-Term Assets $5.5B	CAGR 3-Years 26%	CAGR 5-Years 11%	CAGR 10-Years 10%
	Pfizer Inc NYSE:PFE	Other Long-Term Assets $16.1B	CAGR 3-Years 30%	CAGR 5-Years 26%	CAGR 10-Years 12%
	Merck & Co Inc NYSE:MRK	Other Long-Term Assets $11.1B	CAGR 3-Years 4%	CAGR 5-Years 6%	CAGR 10-Years 2%
	Eli Lilly and Co NYSE:LLY	Other Long-Term Assets $10.3B	CAGR 3-Years 17%	CAGR 5-Years 18%	CAGR 10-Years 16%

See Also

Based on the financial report for Mar 31, 2024, Nektar Therapeutics's Other Long-Term Assets amounts to 4.7m USD.

Over the last year, the Other Long-Term Assets growth was 233%. The average annual Other Long-Term Assets growth rates for Nektar Therapeutics have been 49% over the past three years , 14% over the past five years , and -18% over the past ten years .

Join more than 142,600+ value investors using Alpha Spread

Create a free account

or see our plans & pricing

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

What is Intrinsic Value? Help Center Contact Us

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.